EUVIMEDEUVIMED entdecken
Open Access

Possible dose-dependent effect of eplerenone on intraocular pressure

Seyedeh Mehrsa Sadat Razavi, Ramin Daneshvar

Indian Journal of Ophthalmology · 2023

DOI: 10.4103/ijo.ijo_175_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Seyedeh Mehrsa Sadat Razavi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Florida College of Medicine, Florida, USA. Hauptthemen laut MEDLINE: Intraocular Pressure, Glaucoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Intraocular pressure (IOP) is the main modifiable risk factor for glaucoma. Current therapies target the anterior outflow of aqueous humor or its production. This study aims to demonstrate eplerenone could reduce IOP through a possible posterior outflow path via retinal pigment epithelium (RPE).

Methods

In this retrospective study, IOP changes in patients undergoing eplerenone treatment were investigated. Inclusion criteria were IOP data immediately before and during treatment. Exclusion criteria included ophthalmic procedures, changes in topical glaucoma treatment, or taking systemic medications affecting IOP. After reviewing 162 charts, 41 subjects were eligible. Pearson correlation test was used to investigate the correlation between continuous IOP and eplerenone dosage.

Results

The mean ± SD IOP before eplerenone treatment was 14.31 ± 3.73 mmHg and decreased to 13.50 ± 4.04 mmHg; however, this was not statistically significant ( P = 0.39). In subset of patients with eplerenone dose of more than 25 mg/day and baseline IOP equal to or less than 15 mmHg, the mean IOP before eplerenone treatment was 12.33 ± 2.59 mmHg and decreased to 10.33 ± 2.99, which is a trend toward IOP reduction with a 16% reduction in IOP ( P = 0.055).

Conclusion

A possible dose-dependent decrease in IOP with eplerenone provides indirect evidence for the posterior flow model and suggests the mineralocorticoid receptors (MRs) in RPE play a role in the posterior flow of aqueous humor. It can be deduced that the RPE pumps responsible for the posterior flow of aqueous humor are MR-regulated and their function can be enhanced with MR antagonists.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intraocular PressureGlaucomaHumansEplerenoneRetrospective StudiesTonometry, OcularAqueous Humor

Stichwörter der Autor:innen

EplerenoneIOP ReductionMR antagonistretinal pigment epithelium

Substanzen

Eplerenone

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Florida College of Medicine, Florida, USA.

Zitieren

APA

Razavi, S. M. S., & Daneshvar, R. (2023). Possible dose-dependent effect of eplerenone on intraocular pressure. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_175_23

Vancouver

Razavi SMS, Daneshvar R. Possible dose-dependent effect of eplerenone on intraocular pressure. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_175_23

BibTeX
@article{Razavi2023,
  author = {Razavi, Seyedeh Mehrsa Sadat and Daneshvar, Ramin},
  title = {Possible dose-dependent effect of eplerenone on intraocular pressure},
  journal = {Indian Journal of Ophthalmology},
  year = {2023},
  doi = {10.4103/ijo.ijo_175_23}
}
Kostenlos starten →